NCT05912972

Brief Summary

The goal of this observational study is to identify and analyze the characteristics, treatment trends, prognostic factors and survival prognosis of Korean gynecologic cancer patients. Ultimately, the final goal is to contribute to the development of safe surgical methods and treatment for gynecologic cancer to improve survival rates.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
13,500

participants targeted

Target at P75+ for all trials

Timeline
18mo left

Started Oct 2022

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress71%
Oct 2022Oct 2027

Study Start

First participant enrolled

October 21, 2022

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

June 12, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

June 22, 2023

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 21, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 21, 2027

Last Updated

June 22, 2023

Status Verified

June 1, 2023

Enrollment Period

5 years

First QC Date

June 12, 2023

Last Update Submit

June 12, 2023

Conditions

Cervical CancerEndometrial CancerOvarian CancerFallopian Tube CancerPeritoneal Cancer

Outcome Measures

Primary Outcomes (1)

  • Overall survival

    Analyzed for all patients as time from diagnosis to death as a result of any cause, stratified according to baseline characteristics, surgical methods, and treatment

    5 years

Secondary Outcomes (1)

  • Progression-free survival

    5 years

Study Arms (3)

Cervical cancer

No interventions

Other: Patient registry

Endometrial cancer

No interventions

Other: Patient registry

Ovarian cancer, Fallopian tube cancer, Peritoneal cancer

No interventions

Other: Patient registry

Interventions

Patient registryOTHER

Clinical data, specific procedures and treatments will follow the Institutional standard operative procedures

Cervical cancerEndometrial cancerOvarian cancer, Fallopian tube cancer, Peritoneal cancer

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with gynecologic cancer undergoing treatment

You may qualify if:

  • Female patients 18 years or older
  • Written informed consent (prospective cohort)
  • Confirmed diagnosis of cervical cancer, endometrial cancer or ovarian cancer

You may not qualify if:

  • Unconfirmed diagnosis of cervical cancer, endometrial cancer or ovarian cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center

Seoul, 138-736, South Korea

RECRUITING

MeSH Terms

Conditions

Uterine Cervical NeoplasmsEndometrial NeoplasmsOvarian NeoplasmsFallopian Tube Neoplasms

Condition Hierarchy (Ancestors)

Uterine NeoplasmsGenital Neoplasms, FemaleUrogenital NeoplasmsNeoplasms by SiteNeoplasmsUterine Cervical DiseasesUterine DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital DiseasesEndocrine Gland NeoplasmsOvarian DiseasesAdnexal DiseasesEndocrine System DiseasesGonadal DisordersFallopian Tube Diseases

Study Officials

  • Jeong-Yeol Park, PhD

    Asan Medical Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jeong-Yeol Park, PhD

CONTACT

+82230103646obgyjypark@amc.seoul.kr

So Hyun Nam, MD

CONTACT

+82230100869gynamsh@gmail.com

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
OTHER
Target Duration
3 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 12, 2023

First Posted

June 22, 2023

Study Start

October 21, 2022

Primary Completion (Estimated)

October 21, 2027

Study Completion (Estimated)

October 21, 2027

Last Updated

June 22, 2023

Record last verified: 2023-06

Locations

KR(1)